TrialOpen forum infectious diseases2024

Comparative Effectiveness of Switching to Bictegravir From Dolutegravir-, Efavirenz-, or Raltegravir-Based Antiretroviral Therapy Among Individuals With HIV Who are Virologically Suppressed.

Isaac Núñez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.